Some of the benefits of our solution:
For the organisation:
- Reduction in relapse rate leading to cost efficiency savings
- Consistency in Adherence Therapy management for patients (ie using the same language)
- Improve quality outcomes measures (CQUIN QIPP)
- Improvement in medicines optimisation
- Reduction in medicines wastage
- Promotes collaborative working
For the patient:
- Enhanced understanding of their condition and treatment plan
- Greater feeling of involvement in their care gained from mutual decision making
- Improved quality of life
- More effective management of medication to improve health and wellbeing
For the delegate:
- Gain understanding of factors affecting medication adherence in people with long term illnesses
- Gain understanding of strategies to enhance medication adherence in people with long term illness
- Clinical competence in using the Adherence Therapy assessment and toolkit
- Confidence to talk to patients about medication
For pharmaceutical organisations:
- Greater patient adherence leads to consistent taking of medications as prescribed
- Delivers an opportunity for true joint working with the NHS to give mutually beneficial outcomes
- Supports Value Based Pricing and Value Propositions
